Finance

Lists
Why is 600521 up 2.85%?
Dive Deeper
600521:SHA
Zhejiang Huahai Pharmaceutical Co., Ltd.
CNÂ¥16.98
+2.85%
(+0.47) 1D
Nov 4, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600521...
Open
CNÂ¥16.51
High
CNÂ¥17.08
Low
CNÂ¥16.50
Mkt. cap
24.76B
Avg. vol.
29.33M
Volume
36.73M
Dividend
0.59%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
26.69
52-wk high
CNÂ¥19.16
52-wk low
CNÂ¥13.73
EPS
CNÂ¥0.64
Shares outstanding
1.25B
No. of employees
9K
Open
CNÂ¥16.51
High
CNÂ¥17.08
Low
CNÂ¥16.50
Mkt. cap
24.76B
Avg. vol.
29.33M
Volume
36.73M
Dividend
0.59%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
26.69
52-wk high
CNÂ¥19.16
52-wk low
CNÂ¥13.73
EPS
CNÂ¥0.64
Shares outstanding
1.25B
No. of employees
9K
News stories
From web sources and news partners
About Zhejiang Huahai Pharmaceutical Co., Ltd.
CEO-
Employees8.8K
Founded1989
Headquarters-
SectorPharmaceutical industry
Industry-
Websitehuahaipharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.18B
2.34B
2.58B
2.51B
Cost of goods sold
1.13B
988.64M
1.07B
932.32M
Cost of revenue
1.13B
988.64M
1.07B
932.32M
Research and development expenses
399.64M
218.54M
244.46M
231.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
703.66M
810.07M
756.82M
795.19M
Operating expense
1.15B
1.04B
1.03B
989.74M
Total operating expenses
2.28B
2.03B
2.11B
1.92B
Operating income
-104.23M
308.31M
469.54M
590.28M
Other non operating income
14.72M
-46.77M
44.96M
-252.64M
EBT including unusual items
-105.28M
444.33M
457.70M
385.26M
EBT excluding unusual items
-177.11M
447.80M
336.35M
520.28M
Income tax expense
41.32M
45.99M
88.96M
89.59M
Effective tax rate
-39.25%
10.35%
19.44%
23.25%
Other operating expenses
51.48M
-3.20M
39.10M
-30.17M
Net income
-113.96M
404.18M
366.73M
288.80M
Net profit margin
-5.23%
17.31%
14.23%
11.50%
Earnings per share
-
-
-
-
Interest and investment income
6.97M
249.37M
-
121.56M
Interest expense
-58.06M
-63.11M
-83.05M
-34.03M
Net interest expenses
-51.09M
186.27M
-83.05M
87.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
138.33M
550.87M
733.35M
832.84M
Gain or loss from assets sale
-943.00
-
-23.33M
23.33M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps